Singapore vs Switzerland: Hypertension effective treatment coverage (controlled hypertension)
Singapore
37.6%
in 2019
Switzerland
36.8%
in 2019
Singapore rank
11th
Switzerland rank
12th
Hypertension effective treatment coverage (controlled hypertension) over time
- Singapore
- Switzerland
How they compare
Singapore currently reports 37.6% against 36.8% in Switzerland, a difference of 0.8%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Switzerland ahead.
Singapore ranks 11th and Switzerland ranks 12th of 193 countries.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Singapore | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 6.6% | 9.7% | 3.0% | Switzerland |
| 2000s | 16.4% | 20.3% | 3.9% | Switzerland |
| 2010s | 31.5% | 32.8% | 1.3% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Singapore or Switzerland?
- Singapore, at 37.6% against 36.8% in Switzerland as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Singapore and Switzerland?
- 0.8%, with Singapore ahead.
- How many years of comparable data are there for Singapore and Switzerland?
- 30 years are reported by both, from 1990 to 2019.
- How do Singapore and Switzerland rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Singapore ranks 11th and Switzerland ranks 12th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.